Environmental modulation of amphetamine-induced c-fos expression in D1 versus D2 striatal neurons

Behavioural Brain Research

Volumn 103, Issue 2, 1999, Pages 203-209

  Badiani, Aldo ^a   Oates, Matthew M ^a   Day, Heidi E W ^b   Watson, Stanley J ^b   Akil, Huda ^b   Robinson, Terry E ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

6 Hydroxydopamine(2,4,5 trihydroxyphenethylamine)hydrobromide; Amphetamine; c fos; Caudate; Context; D1; D2; Dopamine; Environment; Novelty; Rotational behavior; Stress; Striatonigral; Striatopallidal; Striatum

Indexed keywords

AMPHETAMINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; ENVIRONMENT; GLOBUS PALLIDUS; HISTOLOGY; IMMEDIATE EARLY GENE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; STRESS;

AMPHETAMINE; ANIMALS; DOPAMINE UPTAKE INHIBITORS; ENVIRONMENT; GENE EXPRESSION; GENES, FOS; IN SITU HYBRIDIZATION; MALE; NEURONS; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RNA, MESSENGER; SYMPATHOLYTICS;

EID: 0033198439     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(99)00041-8     Document Type: Article

References (34)

1. Badiani A., Anagnostaras S., Robinson T.E. The development of sensitization to the psychomotor stimulant effects of amphetamine is enhanced in a novel environment. Psychopharmacology. 117:1995;443-452.
2. Badiani A., Browman K.E., Robinson T.E. Influence of novel versus home environments on sensitization to the psychomotor stimulant effects of cocaine and amphetamine. Brain Res. 674:1995;291-298.
3. Badiani A., Camp D.M., Robinson T.E. Enduring enhancement of amphetamine sensitization by drug-associated environmental stimuli. J Pharmacol Exp Ther. 282:1997;787-794.
4. Badiani A., Oates M.M., Day H.E.W., Watson S.J. Jr., Akil A., Robinson T.E. Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: modulation by environmental novelty. J Neurosci. 18:1998;10579-10593.
5. Badiani A, Oates MM, Fraioli S, Browman KE, Ostrander MM, Xue C-J, Wolf ME, Robinson TE. Amphetamine and novelty: dissociation between effects on behavior and on the release of dopamine and glutamate in the striatal complex. (Submitted).
6. Berretta S., Robertson H.A., Graybiel A.M. Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. J Neurophysiol. 68:1992;767-777.
7. Browman K.E., Badiani A., Robinson T.E. Modulatory effect of environmental stimuli on the susceptibility to amphetamine sensitization: a dose-effect study in rats. J Pharmacol Exp Ther. 287:1998;1007-1014.
8. Castañeda E., Whishaw I.Q., Robinson T.E. Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size. J Neurosci. 10:1990;1847-1854.
9. Cenci M.A., Björklund A. Transection of corticostriatal afferents reduces amphetamine- and apomorphine-induced striatal Fos expression and turning behavior in unilaterally 6-hydroxydopamine-lesioned rats. Eur J Neurosci. 5:1993;1062-1070.
10. Crombag H.S., Badiani A., Robinson T.E. Signalled versus unsignalled intravenous amphetamine: large differences in the acute psychomotor response and sensitization. Brain Res. 722:1996;227-231.
11. Curran E.J., Watson S.J. Jr. Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: a double in situ hybridization study. J Comp Neurol. 361:1995;57-76.
12. Curran E.J., Akil H., Watson S.J. Jr. Psychomotor stimulant- and opiate-induced c-fos mRNA expression patterns in the rat forebrain: comparisons between acute drug treatment and a drug challenge in sensitized animals. Neurochem Res. 21:1996;1425-1435.
13. Fonnum F. Determination of amino acid turnover. Neuromethods. 3:1985;201-237.
14. Genova L.M., Hyman S.E. 5-HT3 receptor activation is required for induction of striatal c-Fos and phosphorylation of ATF-1 by amphetamine. Synapse. 30:1998;71-78.
15. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 15:1992;133-139.
16. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J. Jr., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
17. Gerfen C.R., Keefe K.A., Gauda E.B. D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. J Neurosci. 15:1995;8167-8176.
18. Graybiel A.M., Moratalla R., Robertson H.A. Amphetamine and cocaine induce drug specific activation of the c-fos gene in striosome matrix compartments and limbic subdivisions of the striatum. Proc Natl Acad Sci USA. 87:1990;6912-6916.
19. Hauptmann G., Gerster T. Two colour whole-mount in situ hybridization to vertebrate and drosophila embryos. Trends Genet. 10:1994;266.
20. Hefti F., Melamed E., Sahakian B.J., Wurtman R.J. Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA. Pharmacol Biochem Behav. 12:1980;185-188.
21. Hefti F., Melamed E., Wurtman R.J. Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization. Brain Res. 195:1980;123-137.
22. Heilig M., Engel J.A., Soderpalm B. C-fos antisense in the nucleus accumbens blocks the locomotor stimulant action of cocaine. Eur J Pharmacol. 236:1993;339-340.
23. Heimer L., Zahm D.S., Alheid G.F. Basal ganglia. Paxinos G. The rat nervous system. 2nd ed:1995;689-704 Academic Press, San Diego.
24. Jaber M., Cador M., Dumartin B., Normand E., Stinus L., Bloch B. Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons. Neuroscience. 65:1995;1041-1050.
25. Johansson B., Lindstrom K., Fredholm B.B. Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat. Neuroscience. 59:1994;837-849.
26. Konradi C., Leveque J.C., Hyman S.E. Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J Neurosci. 16:1996;4231-4239.
27. Le Moine C., Bloch B. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J Comp Neurol. 355:1995;418-426.
28. Le Moine C., Svenningsson P., Fredholm B.B., Bloch B. Dopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression. J Neurosci. 17:1997;8038-8048.
29. Nestler E.J., Duman R.S. Intracellular messenger pathways as mediator of neural plasticity. Bloom F.E., Kupfer D.J. Psychopharmacology: the fourth generation of progress. 1995;695-704 Raven Press, New York.
30. Paul M.L., Graybiel A.M., David J.C., Robertson H.A. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J Neurosci. 12:1992;3729-3742.
31. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 2nd ed:1997;Academic Press, San Diego.
32. Robinson T.E., Mocsary Z., Camp D.M., Whishaw I.Q. Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system. J Neurosci. 14:1994;2687-2696.
33. Snyder-Keller A.M. Striatal c-fos induction by drugs and stress in neonatally dopamine-depleted rats given nigral transplants: importance of NMDA activation and relevance to sensitization phenomena. Exp Neurol. 113:1992;155-165.
34. Surmeier D.J., Reiner A., Levine M.S., Ariano M.A. Are neostriatal dopamine receptors co-localized? Trends Neurosci. 16:1993;299-305.